AI-powered search
Try Polaris, our new AI-powered search!

How can topical roflumilast impact quality of life in patients with psoriasis?

Featuring Laura Ferris, MD, PhD |

Professor and Director of Clinical Trials, Dermatology
University of Pittsburgh
Pittsburgh, PA

| Published November 29, 2022

More from this series

Who is a good candidate for lebrikizumab?

Atopic Dermatitis

Who is a good candidate for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for lebrikizumab?

Atopic Dermatitis

What is the dosing regimen for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the safety profile of lebrikizumab?

Atopic Dermatitis

What is the safety profile of lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI